[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4939 followers
Created: 2025-07-14 11:05:54 UTC

$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off.

![](https://pbs.twimg.com/media/Gv0DvVKXoAAumjb.png)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944714969359978990/c:line.svg)

**Related Topics**
[azn astrazeneca](/topic/azn-astrazeneca)
[manat](/topic/manat)
[acquisition](/topic/acquisition)
[$cinc](/topic/$cinc)
[$azn](/topic/$azn)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/doepke_michel/status/1944714969359978990)